Taiwan - Delayed Quote TWD
CHC Healthcare Group (4164.TW)
42.75
+0.45
+(1.06%)
As of 9:07:03 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,950,508
3,600,574
3,877,137
2,974,352
2,439,564
Cost of Revenue
3,113,236
2,841,449
2,808,977
2,072,038
1,590,083
Gross Profit
837,272
759,125
1,068,160
902,314
849,481
Operating Expense
571,532
522,457
454,407
422,397
355,837
Operating Income
265,740
236,668
613,753
479,917
493,644
Net Non Operating Interest Income Expense
-78,871
-72,250
-68,318
-58,737
-52,952
Pretax Income
226,286
223,007
559,430
483,835
491,069
Tax Provision
41,543
40,430
134,192
95,185
110,787
Net Income Common Stockholders
174,523
168,384
418,866
356,571
381,633
Diluted NI Available to Com Stockholders
174,523
168,384
418,866
356,571
381,633
Basic EPS
1.05
1.01
2.55
2.21
2.43
Diluted EPS
1.02
0.98
2.26
1.98
2.18
Basic Average Shares
166,865
166,769
164,454
161,381
157,029
Diluted Average Shares
166,865
194,642
193,571
191,812
185,673
Total Expenses
3,684,768
3,363,906
3,263,384
2,494,435
1,945,920
Net Income from Continuing & Discontinued Operation
174,523
168,384
418,866
356,571
381,633
Normalized Income
173,979.27
166,712.20
419,076.56
359,910.19
381,877.71
Interest Income
24,443
26,102
20,683
12,530
9,564
Interest Expense
103,314
98,352
89,001
71,267
62,516
Net Interest Income
-78,871
-72,250
-68,318
-58,737
-52,952
EBIT
329,600
321,359
648,431
555,102
553,585
EBITDA
976,883
955,326
1,242,894
1,054,484
1,014,177
Reconciled Cost of Revenue
3,113,236
2,841,449
2,808,977
2,072,038
1,590,083
Reconciled Depreciation
647,283
633,967
594,463
499,382
460,592
Net Income from Continuing Operation Net Minority Interest
174,523
168,384
418,866
356,571
381,633
Total Unusual Items Excluding Goodwill
666
2,042
-277
-4,157
-316
Total Unusual Items
666
2,042
-277
-4,157
-316
Normalized EBITDA
976,217
953,284
1,243,171
1,058,641
1,014,493
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
122.27
370.20
-66.44
-817.81
-71.29
12/31/2021 - 10/3/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade